Related Experiment Video
Updated: Apr 18, 2026

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
Published on: September 26, 2025
Pharmacophore modeling using site-identification by ligand competitive saturation (SILCS) with multiple probe
Wenbo Yu1, Sirish Kaushik Lakkaraju, E Prabhu Raman
1Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland , Baltimore, Maryland 21201, United States.
The enhanced Site-Identification by Ligand Competitive Saturation-assisted pharmacophore modeling (SILCS-Pharm) protocol improves drug discovery by better accounting for protein flexibility and solvation. This advanced method enhances lead identification for novel drug design.
Area of Science:
- Computational chemistry
- Drug discovery
- Structural biology
Background:
- Receptor-based pharmacophore modeling is crucial for computer-aided drug design.
- Existing methods often approximate protein flexibility and desolvation, limiting practical applications.
- The Site-Identification by Ligand Competitive Saturation (SILCS) approach addresses these limitations through molecular dynamics simulations.
Purpose of the Study:
- To extend and validate the SILCS-assisted pharmacophore modeling (SILCS-Pharm) protocol.
- To improve the accuracy and scope of pharmacophore modeling by incorporating a wider range of probe molecules.
- To enhance the identification and diversity of potential drug leads.
Main Methods:
- Extended the SILCS-Pharm protocol using diverse probe molecules (e.g., benzene, methanol, acetate) beyond water.
- Utilized full molecular dynamics simulations to generate 3D affinity maps, capturing protein flexibility and desolvation.
- Employed complementary features and volume constraints derived from SILCS exclusion maps.
- Implemented reranking using SILCS-based ligand grid free energies.
Main Results:
- The enhanced SILCS-Pharm protocol demonstrated improved screening results across multiple protein targets compared to the previous version.
- Validation against five additional protein targets showed superior screening performance over common docking methods.
- The inclusion of diverse probe types and features significantly improved the identification of potential drug candidates.
- Reranking enhanced the diversity of identified ligands for most targets.
Conclusions:
- The expanded SILCS-Pharm protocol offers a more robust and accurate approach to receptor-based pharmacophore modeling.
- Explicitly including protein flexibility and desolvation effects with diverse probes enhances lead identification.
- This refined protocol is a valuable tool for rational drug design and discovery.
More Related Videos
Related Concept Videos
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding Sites
Ligand Binding and Linkage
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...

